Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01481077 · ClinicalTrials.gov registry record · Phase 2
A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
A Phase 2 study, sponsored by Mati Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 77
- Enrollment target
NCT01481077 is a Phase 2 study that has completed, run by Mati Therapeutics. The registered enrollment target is 77 participants.
The verdict
NCT01481077, a Phase 2 study, has completed, sponsored by Mati Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 77 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of plug placement on the efficacy, safety and duration of effect of the L-PPDS (latanoprost punctal plug delivery system).
Interventions
- DRUG Latanoprost-PPDS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01481077
The ClinicalTrials.gov registry entry for NCT01481077 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mati Therapeutics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Latanoprost-PPDS is the first listed.
NCT01481077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01481077 about?
NCT01481077 is a clinical study titled "A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma". The purpose of this study is to determine the effect of plug placement on the efficacy, safety and duration of effect of the L-PPDS (latanoprost punctal plug delivery system).
What is the current status of trial NCT01481077?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 77 participants. The study started on 2011-11. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01481077?
The interventions under investigation include: Latanoprost-PPDS (DRUG).
Who is sponsoring clinical trial NCT01481077?
This trial is sponsored by Mati Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.